Refine
Year of publication
Document Type
- Article (83)
- Preprint (8)
- Conference Proceeding (3)
- Diploma Thesis (1)
- Working Paper (1)
Has Fulltext
- yes (96)
Is part of the Bibliography
- no (96)
Keywords
- SARS-CoV-2 (3)
- Accelerators & Beams (2)
- Atomic, Molecular & Optical (2)
- COVID-19 (2)
- NMR spectroscopy (2)
- Outcome (2)
- RNA (2)
- Stroke (2)
- hypoxia (2)
- 3years (1)
- ARDS (1)
- ASCT (1)
- Accelerators & storage rings (1)
- Anti-kaon–nucleon physics (1)
- Aortic valve (1)
- Aortic valve replacement (1)
- Atomic & molecular beams (1)
- Attention-Deficit/Hyperactivity Disorder (ADHD) (1)
- Autism spectrum disorder (1)
- B.1.1.7 (1)
- BI1361849 (1)
- Baryonic resonances (1)
- Beam loss (1)
- Blood flow restriction (1)
- Brain asymmetry (1)
- CHIP (1)
- COVID (1)
- CV9202 (1)
- CVID (1)
- Cardiac surgery (1)
- Cerebrovascular (1)
- Charge-transfer collisions (1)
- Circular accelerators (1)
- Circulating miRNA (1)
- Clinical Trials and Observations (1)
- Clinical competence (1)
- Clinical frailty scale (1)
- Clinical trial (1)
- Contingent Negative Variation, CNV (1)
- Continuous Performance Test, CPT (1)
- Coronary heart disease (1)
- Couch tracking (1)
- Covid19-nmr (1)
- Critical care (1)
- Crystal structure (1)
- Cue-P3 (1)
- DME (1)
- Devic disease (1)
- Devic syndrome (1)
- EEG (1)
- Echovirus-30 (1)
- Ejection fraction (1)
- Electron-pion identification (1)
- Electronic transitions (1)
- Endurance training (1)
- European Society for Immunodeficiencies (ESID) (1)
- Event related potentials (1)
- Experimental models of disease (1)
- FFPE (1)
- Fast-track (1)
- Fibre/foam sandwich radiator (1)
- Flexible Endoscopic Evaluation of Swallowing (1)
- Frailty (1)
- Freezeout (1)
- GRAND-SLAM (1)
- German PID-NET registry (1)
- Gimbaled tracking (1)
- HAI‐1 (1)
- HGF (1)
- HIBCPP cells (1)
- Heavy-ion reactions (1)
- Hemispheric specialization (1)
- Heterogeneity (1)
- High-pressure (1)
- Hyperons (1)
- Hypofractionated radiotherapy (1)
- ICU (1)
- ILUVIEN (1)
- IgG substitution therapy (1)
- Immunomonitoring (1)
- Intensive care outcome (1)
- Ionisation energy loss (1)
- Kaonic nuclei (1)
- Language delay (1)
- Low & intermediate-energy accelerators (1)
- Low energy QCD (1)
- MLC tracking (1)
- Molecular biology (1)
- Multi-wire proportional drift chamber (1)
- Multianvil (1)
- Muscular diseases (1)
- Myeloid Neoplasia (1)
- N501Y (1)
- NADPH oxidase (1)
- NMO-IgG (1)
- NMR (1)
- Nervous system diseases (1)
- Neural network (1)
- Neurofeedback (1)
- Neuromyelitis optica (1)
- Non-small cell lung cancer (1)
- Normative modeling (1)
- Nox1 (1)
- NoxO1 (1)
- Nuclear astrophysics (1)
- Nuclear physics of explosive environments (1)
- Nuclear reactions (1)
- Nucleus (1)
- Organ motion (1)
- PID prevalence (1)
- Partial wave analysis (1)
- Photon counting (1)
- Polarization (1)
- Prognostic models (1)
- Proton (1)
- RNA stability (1)
- RNA, long noncoding (1)
- Radiation detectors (1)
- Radiative capture (1)
- Randomized Controlled Trial (1)
- Rare-earth borate (1)
- Reactive oxygen species (1)
- Readmission (1)
- Response control (1)
- Retro-IDEAL (1)
- Robotic tracking (1)
- SLAM-seq (1)
- SWATH (1)
- Slow Cortical Potentials, SCP (1)
- Stenosis (1)
- Steroid (1)
- Strangeness (1)
- Superoxide (1)
- Sustained attention (1)
- TR (1)
- Telomere length (1)
- Telomeres (1)
- Terbium (1)
- Thrombosis (1)
- Tracking (1)
- Transient (1)
- Transient ischemic attack (1)
- Transition radiation detector (1)
- Trigger (1)
- VIGALL (1)
- VIP1 (1)
- Vertigo (1)
- Water balance (1)
- White blood cells (1)
- Xenon-based gas mixture (1)
- accessory proteins (1)
- accident (1)
- adaptation (1)
- antibiotic therapy (1)
- aquaporin-4 (AQP4) antibody (1)
- arteriogenesis (1)
- autologous stem cell transplantation (1)
- available water capacity (1)
- biomarker (1)
- blood flow restriction (1)
- blood-cerebrospinal fluid barrier (1)
- bone healing (1)
- bone marrow mononuclear cells (1)
- bortezomib (1)
- breast tumor (1)
- cell-free protein synthesis (1)
- cerebrospinal fluid (1)
- chemotherapy (1)
- circulating miRNA (1)
- clinical features (1)
- clonal dominance (1)
- clonal hematopoiesis (1)
- dE/dx (1)
- de novo transcription (1)
- depression (1)
- drought-stress (1)
- drug resistance (1)
- enterovirus (1)
- epidemiology (1)
- epigenomics (1)
- evolution (1)
- fecal microbiota transfer (1)
- forest site classification (1)
- fragment screening (1)
- genetic diversity (1)
- glioblastoma (1)
- graft-vs-host disease (1)
- hematopoietic stem cells (1)
- hematopoietic stress (1)
- hepatitis C virus (HCV) (1)
- heteronuclear detection (1)
- human allogeneic hematopoietic cell transplantation (1)
- human decellularized dermis (1)
- human intestinal microbiota (1)
- hypertension, pulmonary (1)
- imaging (1)
- induced membrane (1)
- induction regimen (1)
- infections: pneumonia, TB, viral (1)
- injury (1)
- intrinsically disordered region (1)
- isotope labeling (1)
- kidney (1)
- large functional RNAs (1)
- lenalidomide (1)
- leukemia (1)
- lipid raft (1)
- lockdown (1)
- longitudinally extensive transverse myelitis (1)
- mRNA active cancer immunotherapy (1)
- macrophage (1)
- magnetic resonance imaging (1)
- miR (1)
- miR-142-5p (1)
- miR-143-3p (1)
- miR-197-3p (1)
- miR-342-3p (1)
- miR-424-5p (1)
- microdosing (1)
- mitochondrial antiviral signaling protein (MAVS) (1)
- molecular adaptation (1)
- molecular biology (1)
- molecular dynamics (1)
- molecular surveillance (1)
- monocytes (1)
- multiple myeloma (1)
- natural selection (1)
- neovascularization, physiologic (1)
- nonstructural proteins (1)
- obesity (1)
- p47phox (1)
- pediatric intensive care (1)
- peripheral artery disease (1)
- ppK − (1)
- pressure cycling technology (1)
- primary immunodeficiency (PID) (1)
- proliferation (1)
- protease inhibitor (1)
- proteome (1)
- recurrent optic neuritis (1)
- registry for primary immunodeficiency (1)
- renal failure (1)
- replicative fitness (1)
- resistance mutation (1)
- serine protease (NS3-4A) (1)
- site classification system (1)
- sleepiness (1)
- somatic mutations (1)
- spike mutation (1)
- strength training (1)
- structural proteins (1)
- structure constraints (1)
- trauma (1)
- tumor (1)
- tumor microenvironment (1)
- tumor‐associated macrophages (1)
- viral infection (1)
- x-ray techniques (1)
Institute
- Medizin (53)
- Physik (26)
- Buchmann Institut für Molekulare Lebenswissenschaften (BMLS) (5)
- ELEMENTS (5)
- Geowissenschaften (5)
- Biochemie und Chemie (4)
- Frankfurt Institute for Advanced Studies (FIAS) (4)
- Informatik (4)
- Sonderforschungsbereiche / Forschungskollegs (3)
- Biochemie, Chemie und Pharmazie (2)
This paper reports on Monte Carlo simulation results for future measurements of the moduli of time-like proton electromagnetic form factors, |GE | and |GM|, using the ¯pp → μ+μ− reaction at PANDA (FAIR). The electromagnetic form factors are fundamental quantities parameterizing the electric and magnetic structure of hadrons. This work estimates the statistical and total accuracy with which the form factors can be measured at PANDA, using an analysis of simulated data within the PandaRoot software framework. The most crucial background channel is ¯pp → π+π−,due to the very similar behavior of muons and pions in the detector. The suppression factors are evaluated for this and all other relevant background channels at different values of antiproton beam momentum. The signal/background separation is based on a multivariate analysis, using the Boosted Decision Trees method. An expected background subtraction is included in this study, based on realistic angular distribuations of the background contribution. Systematic uncertainties are considered and the relative total uncertainties of the form factor measurements are presented.
Children’s and adolescents’ lives drastically changed during COVID lockdowns worldwide. To compare accident- and injury-related admissions to pediatric intensive care units (PICU) during the first German COVID lockdown with previous years, we conducted a retrospective multicenter study among 37 PICUs (21.5% of German PICU capacities). A total of 1444 admissions after accidents or injuries during the first lockdown period and matched periods of 2017–2019 were reported and standardized morbidity ratios (SMR) were calculated. Total PICU admissions due to accidents/injuries declined from an average of 366 to 346 (SMR 0.95 (CI 0.85–1.05)). Admissions with trauma increased from 196 to 212 (1.07 (0.93–1.23). Traffic accidents and school/kindergarten accidents decreased (0.77 (0.57–1.02 and 0.26 (0.05–0.75)), whereas household and leisure accidents increased (1.33 (1.06–1.66) and 1.34 (1.06–1.67)). Less neurosurgeries and more visceral surgeries were performed (0.69 (0.38–1.16) and 2.09 (1.19–3.39)). Non-accidental non-suicidal injuries declined (0.73 (0.42–1.17)). Suicide attempts increased in adolescent boys (1.38 (0.51–3.02)), but decreased in adolescent girls (0.56 (0.32–0.79)). In summary, changed trauma mechanisms entailed different surgeries compared to previous years. We found no evidence for an increase in child abuse cases requiring intensive care. The increase in suicide attempts among boys demands investigation.
MicroRNAs (miRNAs) are critical post-transcriptional regulators in many biological processes. They act by guiding RNA-induced silencing complexes to miRNA response elements (MREs) in target mRNAs, inducing translational inhibition and/or mRNA degradation. Functional MREs are expected to predominantly occur in the 3' untranslated region and involve perfect base-pairing of the miRNA seed. Here, we generate a high-resolution map of miR-181a/b-1 (miR-181) MREs to define the targeting rules of miR-181 in developing murine T-cells. By combining a multi-omics approach with computational high-resolution analyses, we uncover novel miR-181 targets and demonstrate that miR-181 acts predominantly through RNA destabilization. Importantly, we discover an alternative seed match and identify a distinct set of targets with repeat elements in the coding sequence which are targeted by miR-181 and mediate translational inhibition. In conclusion, deep profiling of MREs in primary cells is critical to expand physiologically relevant targetomes and establish context-dependent miRNA targeting rules.
Background: To perform a comprehensive study on the relationship between vitamin D metabolism and the response to interferon-α-based therapy of chronic hepatitis C.
Methodology/Principal Findings: Associations between a functionally relevant polymorphism in the gene encoding the vitamin D 1α-hydroxylase (CYP27B1-1260 rs10877012) and the response to treatment with pegylated interferon-α (PEG-IFN-α) and ribavirin were determined in 701 patients with chronic hepatitis C. In addition, associations between serum concentrations of 25-hydroxyvitamin D3 (25[OH]D3) and treatment outcome were analysed. CYP27B1-1260 rs10877012 was found to be an independent predictor of sustained virologic response (SVR) in patients with poor-response IL28B genotypes (15% difference in SVR for rs10877012 genotype AA vs. CC, p = 0.02, OR = 1.52, 95% CI = 1.061–2.188), but not in patients with favourable IL28B genotype. Patients with chronic hepatitis C showed a high prevalence of vitamin D insufficiency (25[OH]D3<20 ng/mL) during all seasons, but 25(OH)D3 serum levels were not associated with treatment outcome.
Conclusions/Significance: Our study suggests a role of bioactive vitamin D (1,25[OH]2D3, calcitriol) in the response to treatment of chronic hepatitis C. However, serum concentration of the calcitriol precursor 25(OH)D3 is not a suitable predictor of treatment outcome.
Background: Vitamin D insufficiency has been associated with the occurrence of various types of cancer, but causal relationships remain elusive. We therefore aimed to determine the relationship between genetic determinants of vitamin D serum levels and the risk of developing hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC).
Methodology/Principal Findings: Associations between CYP2R1, GC, and DHCR7 genotypes that are determinants of reduced 25-hydroxyvitamin D (25[OH]D3) serum levels and the risk of HCV-related HCC development were investigated for 1279 chronic hepatitis C patients with HCC and 4325 without HCC, respectively. The well-known associations between CYP2R1 (rs1993116, rs10741657), GC (rs2282679), and DHCR7 (rs7944926, rs12785878) genotypes and 25(OH)D3 serum levels were also apparent in patients with chronic hepatitis C. The same genotypes of these single nucleotide polymorphisms (SNPs) that are associated with reduced 25(OH)D3 serum levels were found to be associated with HCV-related HCC (P = 0.07 [OR = 1.13, 95% CI = 0.99–1.28] for CYP2R1, P = 0.007 [OR = 1.56, 95% CI = 1.12–2.15] for GC, P = 0.003 [OR = 1.42, 95% CI = 1.13–1.78] for DHCR7; ORs for risk genotypes). In contrast, no association between these genetic variations and liver fibrosis progression rate (P>0.2 for each SNP) or outcome of standard therapy with pegylated interferon-α and ribavirin (P>0.2 for each SNP) was observed, suggesting a specific influence of the genetic determinants of 25(OH)D3 serum levels on hepatocarcinogenesis.
Conclusions/Significance: Our data suggest a relatively weak but functionally relevant role for vitamin D in the prevention of HCV-related hepatocarcinogenesis.
The highly infectious disease COVID-19 caused by the Betacoronavirus SARS-CoV-2 poses a severe threat to humanity and demands the redirection of scientific efforts and criteria to organized research projects. The international COVID19-NMR consortium seeks to provide such new approaches by gathering scientific expertise worldwide. In particular, making available viral proteins and RNAs will pave the way to understanding the SARS-CoV-2 molecular components in detail. The research in COVID19-NMR and the resources provided through the consortium are fully disclosed to accelerate access and exploitation. NMR investigations of the viral molecular components are designated to provide the essential basis for further work, including macromolecular interaction studies and high-throughput drug screening. Here, we present the extensive catalog of a holistic SARS-CoV-2 protein preparation approach based on the consortium’s collective efforts. We provide protocols for the large-scale production of more than 80% of all SARS-CoV-2 proteins or essential parts of them. Several of the proteins were produced in more than one laboratory, demonstrating the high interoperability between NMR groups worldwide. For the majority of proteins, we can produce isotope-labeled samples of HSQC-grade. Together with several NMR chemical shift assignments made publicly available on covid19-nmr.com, we here provide highly valuable resources for the production of SARS-CoV-2 proteins in isotope-labeled form.